Study guide

profilemelissamarie
HCR240Module2LearningGuide.pdf

HCR 240 Module 2 Learning Guide

MODULE REFLECTION – In the box below, reflect on the course material & activities for this module. If you did not complete all the activities, did you have any questions or comments relating to this? What content did you find the most interesting and why? This should be a 4-5 sentence paragraph.

MODULE 2 DISORDERS OR DISEASES Diseases to know for Module 2, include etiology, typical signs and symptoms, diagnostic testing, and general treatment (or prognosis). Use your textbook and/or supplemental PowerPoint for the completion of this table. Complete sentences are NOT required. It is important to be succinct in your analysis of each disease and choose the most important components to look for in a clinical setting. For this reason, do not include more than 5 different components in each box.

Disease or Disorder (Chapter)

Etiology (cause) and/or Risk Factors

Signs & Symptoms of Disease (Clinical Manifestations)

Diagnostic Testing / Assessment

Possible Treatments and/or Prognosis

Systemic Lupus Erythematosus (SLE) (Ch. 11)

Rheumatoid arthritis (RA) (Ch. 11)

Severe Combined Immunodeficiency Disease (SCID) (Ch. 11)

pg. 1 of 6

HCR 240 Module 2 Learning Guide

Disease or Disorder (Chapter)

Etiology (cause) and/or Risk Factors

Signs & Symptoms of Disease (Clinical Manifestations)

Diagnostic Testing / Assessment

Possible Treatments and/or Prognosis

Selective IgA Deficiency (Ch. 11)

DiGeorge Syndrome (Ch. 11)

HIV (Ch. 11)

Acute Lymphoblastic Leukemia (Ch. 12)

Chronic Lymphocytic Leukemia (Ch. 12)

Lymphoma (Hodgkin’s, Non-Hodgkin’s) (Ch. 12)

Hodgkin’s:

Non-Hodgkin’s:

Anemia (decrease in RBC Mass) (Ch. 13)

pg. 2 of 6

HCR 240 Module 2 Learning Guide

Disease or Disorder (Chapter)

Etiology (cause) and/or Risk Factors

Signs & Symptoms of Disease (Clinical Manifestations)

Diagnostic Testing / Assessment

Possible Treatments and/or Prognosis

Anemia (Acute blood loss) (Ch. 13)

Anemia (Chronic Blood Loss) (Ch. 13)

Hemolytic Anemia (Ch. 13)

Sickle Cell Anemia (Ch. 13)

Hemolytic Disease of a Newborn (Ch. 13)

Iron-Deficiency Anemia (Ch. 13)

Immune Thrombocytopenic Purpura (ITP) (Ch. 14)

Hemophilia (Ch. 14)

pg. 3 of 6

HCR 240 Module 2 Learning Guide

Disease or Disorder (Chapter)

Etiology (cause) and/or Risk Factors

Signs & Symptoms of Disease (Clinical Manifestations)

Diagnostic Testing / Assessment

Possible Treatments and/or Prognosis

Hemolytic-Uremic Syndrome (Ch 14)

Hyperlipidemia (Ch. 15)

Hypertension (Ch. 15)

Atherosclerosis (Ch. 15)

Aneurysm (Ch. 15)

Kawasaki Disease (Ch. 15)

pg. 4 of 6

HCR 240 Module 2 Learning Guide

CHAPTER 11 – DISORDERS OF IMMUNE SYSTEM - Compare the four types of hypersensitivity disorders. Hypersensitivity Description of Response Signs & Symptoms Example

Type I

Type II

Type III

Type IV

pg. 5 of 6

HCR 240 Module 2 Learning Guide

MODULE 2 OTHER TERMS TO KNOW The terms below outline some additional pathophysiology terms to know for the midterm exam in Module 4. You are NOT required to define them in this module study guide; however, all terms can be seen in the Module Knowledge Check and Midterm Exam.

Chapter 11: Disorders of the Immune System Terms • Immunodeficiency • Autoimmunity • Hypersensitivity • Allergy • Urticaria • Anaphylaxis • AIDS

Chapter 12: Disorders of the White Blood Cells Terms • Leukocytosis • Leukopenia • Neutrophilia • WBC Count of all Leukocytes • Hematologic neoplasms • Leukemia • Lymphoma • Immunotherapy

Chapter 13: Disorders of the Red Blood Cells Terms • Anemia • Polycythemia • Complete Blood Count • Hemoglobin • Hematocrit • Hemolytic

Chapter 14: Disorders of Platelets, Hemostasis, and Coagulation Terms

• Hemostasis • Thrombus • Thrombocytopenia • Thrombocytosis • Embolism • Heparin

Chapter 15: Arterial Disorders Terms • Arteries • Arteriosclerosis • Atherosclerosis • LDL • HDL • Plaque • Blood Pressure • Aneurysm • Vasculitis

pg. 6 of 6

  • Module Reflection –
  • MODULE 2 Disorders or Diseases
  • Chapter 11 – Disorders of Immune System - Compare the four types of hypersensitivity disorders.
  • MODULE 2 Other Terms to Know
    • Chapter 11: Disorders of the Immune System Terms
    • Chapter 12: Disorders of the White Blood Cells Terms
    • Chapter 13: Disorders of the Red Blood Cells Terms
    • Chapter 14: Disorders of Platelets, Hemostasis, and Coagulation Terms
    • Chapter 15: Arterial Disorders Terms
  1. Etiology cause andor Risk FactorsSystemic Lupus Erythematosus SLE Ch 11:
  2. Signs Symptoms of Disease Clinical ManifestationsSystemic Lupus Erythematosus SLE Ch 11:
  3. Diagnostic Testing AssessmentSystemic Lupus Erythematosus SLE Ch 11:
  4. Possible Treatments andor PrognosisSystemic Lupus Erythematosus SLE Ch 11:
  5. Etiology cause andor Risk FactorsRheumatoid arthritis RA Ch 11:
  6. Signs Symptoms of Disease Clinical ManifestationsRheumatoid arthritis RA Ch 11:
  7. Diagnostic Testing AssessmentRheumatoid arthritis RA Ch 11:
  8. Possible Treatments andor PrognosisRheumatoid arthritis RA Ch 11:
  9. Etiology cause andor Risk FactorsSevere Combined Immunodeficiency Disease SCID Ch 11:
  10. Signs Symptoms of Disease Clinical ManifestationsSevere Combined Immunodeficiency Disease SCID Ch 11:
  11. Diagnostic Testing AssessmentSevere Combined Immunodeficiency Disease SCID Ch 11:
  12. Possible Treatments andor PrognosisSevere Combined Immunodeficiency Disease SCID Ch 11:
  13. Etiology cause andor Risk FactorsSelective IgA Deficiency Ch 11:
  14. Signs Symptoms of Disease Clinical ManifestationsSelective IgA Deficiency Ch 11:
  15. Diagnostic Testing AssessmentSelective IgA Deficiency Ch 11:
  16. Possible Treatments andor PrognosisSelective IgA Deficiency Ch 11:
  17. Etiology cause andor Risk FactorsDiGeorge Syndrome Ch 11:
  18. Signs Symptoms of Disease Clinical ManifestationsDiGeorge Syndrome Ch 11:
  19. Diagnostic Testing AssessmentDiGeorge Syndrome Ch 11:
  20. Possible Treatments andor PrognosisDiGeorge Syndrome Ch 11:
  21. Etiology cause andor Risk FactorsHIV Ch 11:
  22. Signs Symptoms of Disease Clinical ManifestationsHIV Ch 11:
  23. Diagnostic Testing AssessmentHIV Ch 11:
  24. Possible Treatments andor PrognosisHIV Ch 11:
  25. Etiology cause andor Risk FactorsAcute Lymphoblastic Leukemia Ch 12:
  26. Signs Symptoms of Disease Clinical ManifestationsAcute Lymphoblastic Leukemia Ch 12:
  27. Diagnostic Testing AssessmentAcute Lymphoblastic Leukemia Ch 12:
  28. Possible Treatments andor PrognosisAcute Lymphoblastic Leukemia Ch 12:
  29. Etiology cause andor Risk FactorsChronic Lymphocytic Leukemia Ch 12:
  30. Signs Symptoms of Disease Clinical ManifestationsChronic Lymphocytic Leukemia Ch 12:
  31. Diagnostic Testing AssessmentChronic Lymphocytic Leukemia Ch 12:
  32. Possible Treatments andor PrognosisChronic Lymphocytic Leukemia Ch 12:
  33. Signs Symptoms of Disease Clinical ManifestationsHodgkins NonHodgkins:
  34. Diagnostic Testing AssessmentHodgkins NonHodgkins:
  35. Possible Treatments andor PrognosisHodgkins NonHodgkins:
  36. Hodgkins NonHodgkinsAnemia decrease in RBC Mass Ch 13:
  37. Signs Symptoms of Disease Clinical ManifestationsAnemia decrease in RBC Mass Ch 13:
  38. Diagnostic Testing AssessmentAnemia decrease in RBC Mass Ch 13:
  39. Possible Treatments andor PrognosisAnemia decrease in RBC Mass Ch 13:
  40. Etiology cause andor Risk FactorsAnemia Acute blood loss Ch 13:
  41. Signs Symptoms of Disease Clinical ManifestationsAnemia Acute blood loss Ch 13:
  42. Diagnostic Testing AssessmentAnemia Acute blood loss Ch 13:
  43. Possible Treatments andor PrognosisAnemia Acute blood loss Ch 13:
  44. Etiology cause andor Risk FactorsAnemia Chronic Blood Loss Ch 13:
  45. Signs Symptoms of Disease Clinical ManifestationsAnemia Chronic Blood Loss Ch 13:
  46. Diagnostic Testing AssessmentAnemia Chronic Blood Loss Ch 13:
  47. Possible Treatments andor PrognosisAnemia Chronic Blood Loss Ch 13:
  48. Etiology cause andor Risk FactorsHemolytic Anemia Ch 13:
  49. Signs Symptoms of Disease Clinical ManifestationsHemolytic Anemia Ch 13:
  50. Diagnostic Testing AssessmentHemolytic Anemia Ch 13:
  51. Possible Treatments andor PrognosisHemolytic Anemia Ch 13:
  52. Etiology cause andor Risk FactorsSickle Cell Anemia Ch 13:
  53. Signs Symptoms of Disease Clinical ManifestationsSickle Cell Anemia Ch 13:
  54. Diagnostic Testing AssessmentSickle Cell Anemia Ch 13:
  55. Possible Treatments andor PrognosisSickle Cell Anemia Ch 13:
  56. Etiology cause andor Risk FactorsHemolytic Disease of a Newborn Ch 13:
  57. Signs Symptoms of Disease Clinical ManifestationsHemolytic Disease of a Newborn Ch 13:
  58. Diagnostic Testing AssessmentHemolytic Disease of a Newborn Ch 13:
  59. Possible Treatments andor PrognosisHemolytic Disease of a Newborn Ch 13:
  60. Etiology cause andor Risk FactorsIronDeficiency Anemia Ch 13:
  61. Signs Symptoms of Disease Clinical ManifestationsIronDeficiency Anemia Ch 13:
  62. Diagnostic Testing AssessmentIronDeficiency Anemia Ch 13:
  63. Possible Treatments andor PrognosisIronDeficiency Anemia Ch 13:
  64. Etiology cause andor Risk FactorsImmune Thrombocytopenic Purpura ITP Ch 14:
  65. Signs Symptoms of Disease Clinical ManifestationsImmune Thrombocytopenic Purpura ITP Ch 14:
  66. Diagnostic Testing AssessmentImmune Thrombocytopenic Purpura ITP Ch 14:
  67. Possible Treatments andor PrognosisImmune Thrombocytopenic Purpura ITP Ch 14:
  68. Etiology cause andor Risk FactorsHemophilia Ch 14:
  69. Signs Symptoms of Disease Clinical ManifestationsHemophilia Ch 14:
  70. Diagnostic Testing AssessmentHemophilia Ch 14:
  71. Possible Treatments andor PrognosisHemophilia Ch 14:
  72. Etiology cause andor Risk FactorsHemolyticUremic Syndrome Ch 14:
  73. Signs Symptoms of Disease Clinical ManifestationsHemolyticUremic Syndrome Ch 14:
  74. Diagnostic Testing AssessmentHemolyticUremic Syndrome Ch 14:
  75. Possible Treatments andor PrognosisHemolyticUremic Syndrome Ch 14:
  76. Etiology cause andor Risk FactorsHyperlipidemia Ch 15:
  77. Signs Symptoms of Disease Clinical ManifestationsHyperlipidemia Ch 15:
  78. Diagnostic Testing AssessmentHyperlipidemia Ch 15:
  79. Possible Treatments andor PrognosisHyperlipidemia Ch 15:
  80. Etiology cause andor Risk FactorsHypertension Ch 15:
  81. Signs Symptoms of Disease Clinical ManifestationsHypertension Ch 15:
  82. Diagnostic Testing AssessmentHypertension Ch 15:
  83. Possible Treatments andor PrognosisHypertension Ch 15:
  84. Etiology cause andor Risk FactorsAtherosclerosis Ch 15:
  85. Signs Symptoms of Disease Clinical ManifestationsAtherosclerosis Ch 15:
  86. Diagnostic Testing AssessmentAtherosclerosis Ch 15:
  87. Possible Treatments andor PrognosisAtherosclerosis Ch 15:
  88. Etiology cause andor Risk FactorsAneurysm Ch 15:
  89. Signs Symptoms of Disease Clinical ManifestationsAneurysm Ch 15:
  90. Diagnostic Testing AssessmentAneurysm Ch 15:
  91. Possible Treatments andor PrognosisAneurysm Ch 15:
  92. Etiology cause andor Risk FactorsKawasaki Disease Ch 15:
  93. Signs Symptoms of Disease Clinical ManifestationsKawasaki Disease Ch 15:
  94. Diagnostic Testing AssessmentKawasaki Disease Ch 15:
  95. Possible Treatments andor PrognosisKawasaki Disease Ch 15:
  96. Description of ResponseType I:
  97. Signs SymptomsType I:
  98. ExampleType I:
  99. Description of ResponseType II:
  100. Signs SymptomsType II:
  101. ExampleType II:
  102. Description of ResponseType III:
  103. Signs SymptomsType III:
  104. ExampleType III:
  105. Description of ResponseType IV:
  106. Signs SymptomsType IV:
  107. ExampleType IV:
  108. Etiology Hodgkins:
  109. Etiology NonHodgkins:
  110. ModuleReflection: